Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Nafamostat mesilate for filter patency in CRRT
NCT01761994Phase 4Completed
- Sponsor
- Yonsei University
- Start
- Sep 2007
- Primary completion
- Aug 2010
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of Nafabelltan in acute kidney injury (AKI), sponsored by Yonsei University. Started Sep 2007; status: completed.
02
Drugs
Nafabelltan
03
Conditions
acute kidney injury (AKI)
Beyond the preview
Go deeper on NCT01761994.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01761994.